Newcomb Tara M, Flanigan Kevin M
Department of Neurology (T.M.N.), the University of Utah School of Medicine, Salt Lake City; The Center for Gene Therapy (K.M.F.), Nationwide Children's Hospital, Columbus, OH; and Departments of Pediatrics and Neurology (K.M.F.), Ohio State University, Columbus.
Neurol Genet. 2016 Oct 5;2(5):e108. doi: 10.1212/NXG.0000000000000108. eCollection 2016 Oct.
The cloning of the gene, and the identifications of mutations in it as the cause of Duchenne muscular dystrophy (DMD), makes a compelling story that is aptly told elsewhere. The locus-the largest in the human genome-consists of 79 exons, distributed over 2.5 million nucleotides on the X chromosome, which are assembled into a complementary DNA (cDNA) of around 14 kb encoding the predominant muscle isoform of the dystrophin protein. The size of the gene, and the number of exons, had historically made mutation analysis challenging. For more than a decade, the standard clinical assay was a multiplex PCR test that amplified sequences from a limited number of exons; nevertheless, because it included exons within the deletion hotspots of the gene, this method could confirm the presence of mutations in up to 98% of boys with exonic deletions..
该基因的克隆以及其中突变被鉴定为杜氏肌营养不良症(DMD)的病因,构成了一个引人入胜的故事,在其他地方已有恰当的讲述。该基因座是人类基因组中最大的,由79个外显子组成,分布在X染色体上超过250万个核苷酸上,这些外显子被组装成一个约14 kb的互补DNA(cDNA),编码抗肌萎缩蛋白的主要肌肉同工型。该基因的大小和外显子数量,从历史上看使得突变分析具有挑战性。十多年来,标准临床检测是一种多重PCR检测,可扩增有限数量外显子的序列;然而,由于它包括该基因缺失热点内的外显子,这种方法可以在高达98%的外显子缺失男孩中确认突变的存在。